Search
for
Sort by
Research 91–120 of 347
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- The JAK/STAT signaling pathway: from bench to clinic
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Hair Loss and Androgen’s Role in the Era of COVID-19
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Recommendations on trichological treatments during COVID-19 pandemic
- Poster Abstracts
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Cutaneous signs in COVID ‐19 patients: A review
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity